Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0GTZGW
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Rituximab-MMAE (K248)
|
|||||
| Synonyms |
Rituximab-MMAE (K248)
Click to Show/Hide
|
|||||
| Organization |
Ajinomoto Co., Inc.; Ajinomoto Bio-Pharma Services.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.6
|
|||||
| Structure |
|
|||||
| Antibody Name |
Rituximab
|
Antibody Info | ||||
| Antigen Name |
B-lymphocyte antigen CD20 (MS4A1)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||